Chemotherapy, radiation, and other therapies for colorectal cancer
Your doctor may recommend chemotherapy, radiation therapy, immunotherapy targeted therapy, and/or other therapies to treat colorectal cancer.
Treatment therapies
Your doctor may recommend chemotherapy, radiation therapy, immunotherapy, and/or other therapies to treat your cancer.
How is my type of treatment determined?
Treatment for colorectal cancer depends on several factors including the:
- location of the tumor
- stage of the cancer
- tumor pathology
- overall health of a patient
Every case is different. Your best resource is your doctor, who knows the specific details about your diagnosis.
Common therapies for colorectal cancer
Chemotherapy
Chemotherapy is treatment with cytotoxic drugs that are injected into a vein (IV) or pills taken by mouth. These drugs travel through the bloodstream and destroy cancer cells.
Radiation therapy
Radiation therapy is a form of cancer treatment that uses high-energy rays to destroy cancer cells. Rectal cancer is treated with radiation more frequently than colon cancer.
Immunotherapy
Cancer immunotherapy, also known as immuno-oncology or biological therapy, is a form of cancer treatment that uses the body’s own immune system to help prevent, control, and eliminate cancer.
Targeted therapy
Targeted therapy uses drugs to target and "turn off" specific genes and proteins that help cancer cells grow.
Liver-directed therapy
There are a number of therapies that use chemotherapy, HAI therapy, ablation, radiation, cryotherapy, heat, and other approaches to reduce or remove liver metastases.
HAI therapy
Hepatic Artery Infusion (HAI) therapy is an FDA-approved cancer treatment that delivers medicine into the liver through the hepatic artery.
More about treatment
ChemotherapyTop resources
Lexie Haglund: Beating stage IV CRC
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.
HAI liver pump for mCRC offers second chances
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.
Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.
